Feb 6, 2020

From mushrooms to ecstasy, a renaissance in psychedelics research

Posted by in categories: biotech/medical, neuroscience

MDMA and psilocybin have been granted breakthrough therapy status by the FDA, signaling a shift in the future of mental health treatment.

Clinical studies are underway. How we treat them moving forward matters.

Comments are closed.